Synergism in the Pathogenesis of EAE Induced by an MBP-Specific T-Cell Line and Monoclonal Antibodies to Galactocerebroside or a Myelin Oligodendroglial Glycoprotein†

  1. W. FIERZ1,
  2. K. HEININGER2,
  3. B. SCHAEFER2,
  4. K. V. TOYKA2,
  5. C. LININGTON3,
  6. H. LASSMANN4

Article first published online: 17 DEC 2006

DOI: 10.1111/j.1749-6632.1988.tb27099.x

Issue

Annals of the New York Academy of Sciences

Annals of the New York Academy of Sciences

Volume 540, Advances in Neuroimmunology pages 360–363, November 1988

Additional Information

How to Cite

FIERZ, W., HEININGER, K., SCHAEFER, B., TOYKA, K. V., LININGTON, C. and LASSMANN, H. (1988), Synergism in the Pathogenesis of EAE Induced by an MBP-Specific T-Cell Line and Monoclonal Antibodies to Galactocerebroside or a Myelin Oligodendroglial Glycoprotein. Annals of the New York Academy of Sciences, 540: 360–363. doi: 10.1111/j.1749-6632.1988.tb27099.x

Author Information

  1. 1

    Section of Clinical Immunology University Hospital Zürich, Switzerland

  2. 2

    Department of Neurology University of Düsseldorf Düsseldorf, Federal Republic of Germany

  3. 3

    Department of Medicine University of Wales Cardiff, Wales, Great Britain

  4. 4

    Department of Neurology University of Vienna Vienna, Austria

  • †

    This work was supported by the Schweiz. Nationalfonds project no. 3.998–0.86 and the Deutsche Forschungsgemeinschaft SFB 200/B5.

Publication History

  1. Issue published online: 17 DEC 2006
  2. Article first published online: 17 DEC 2006

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

Get PDF (158K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Melanie D. Harrer, Hans-Christian von Büdingen, Luc Stoppini, Chantal Alliod, Sandrine Pouly, Katja Fischer, Norbert Goebels, Live imaging of remyelination after antibody-mediated demyelination in an ex-vivo model for immune mediated CNS damage, Experimental Neurology, 2009, 216, 2, 431

    CrossRef

  2. 2
    Thomas Berger, Markus Reindl, Multiple sclerosis: Disease biomarkers as indicated by pathophysiology, Journal of the Neurological Sciences, 2007, 259, 1-2, 21

    CrossRef

  3. 3
    Alan G. Baxter, The origin and application of experimental autoimmune encephalomyelitis, Nature Reviews Immunology, 2007, 7, 11, 904

    CrossRef

  4. 4
    Markus Reindl, Michael Khalil, Thomas Berger, Antibodies as biological markers for pathophysiological processes in MS, Journal of Neuroimmunology, 2006, 180, 1-2, 50

    CrossRef

  5. 5
    Thomas Berger, Markus Reindl, Emergence of antibodies as biomarkers in multiple sclerosis, Future Neurology, 2006, 1, 1, 57

    CrossRef

  6. 6
    Christopher C. LaGanke, Deborah W. Freeman, John N. Whitaker, Cross-reactive idiotypy in cerebrospinal fluid immunoglobulins in multiple sclerosis, Annals of Neurology, 2000, 47, 1
    Direct Link:
  7. 7
    Ming-Lang Zhao, Robert B Fritz, Acute and relapsing experimental autoimmune encephalomyelitis in IL-4- and α/β T cell-deficient C57BL/6 mice, Journal of Neuroimmunology, 1998, 87, 1-2, 171

    CrossRef

  8. 8
    John K. Fazakerley, Michael J. Buchmeiert, 1993,

    CrossRef

Get PDF (158K)